Rasagiline Viatris (previously Rasagiline Mylan)

Rasagiline Viatris is a medicine used to treat adults with Parkinson’s disease (a progressive brain disorder that causes shaking, slow movement and muscle stiffness). Rasagiline Viatris can be used either alone, or as an add\-on to levodopa (another medicine used in Parkinson’s disease) in patients who are having fluctuations in the control of their condition. Fluctuations happen when the effects of the medication wear off and symptoms re\-emerge before the next dose is due. They are linked to a reduction in the effect of levodopa, when the patient experiences sudden switches between being ‘on’ and able to move, and being ‘off’ and having difficulty moving about. Rasagiline Viatris contains the active substance rasagiline and is a ‘generic medicine’. This means that Rasagiline Viatris contains the same active substance and works in the same way as a ‘reference medicine’ already authorised in the EU. The reference medicine for Rasagiline Viatris is Azilect.